Mankind Pharma 35th AGM notice set for August 4, 2026 via VC

Board & Shareholder Meetings View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.4%1-day move

₹2540.00

prior close

₹2543.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.4-0.4-0.2+0.1-1.4-0.5+0.0+0.4-2.4+1.4————

Up moveDown movePending

AI summary

Mankind Pharma has set its 35th AGM for August 4, 2026 at 3:30 PM via video conferencing. Items include adoption of FY2025-26 audited results, re-appointment of Vice Chairman Rajeev Juneja by rotation, and re-appointment of Satish Kumar Sharma as Whole Time Director for 5 years from September 22, 2026 with fixed pay of about Rs 1.32 crore. Members will ratify cost auditor fee of Rs 25.50 lakh for FY27. Remote e-voting runs August 1-3.

Likely market impact

Routine AGM items covering director re-appointments, results adoption, and cost auditor fee ratification. No material impact on the stock is expected.